BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15927989)

  • 1. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.
    Kishi T; Hirooka Y; Masumoto A; Ito K; Kimura Y; Inokuchi K; Tagawa T; Shimokawa H; Takeshita A; Sunagawa K
    Circulation; 2005 May; 111(21):2741-7. PubMed ID: 15927989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans.
    Masumoto A; Hirooka Y; Shimokawa H; Hironaga K; Setoguchi S; Takeshita A
    Hypertension; 2001 Dec; 38(6):1307-10. PubMed ID: 11751708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.
    Hirooka Y; Imaizumi T; Tagawa T; Shiramoto M; Endo T; Ando S; Takeshita A
    Circulation; 1994 Aug; 90(2):658-68. PubMed ID: 8044935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking, endothelial function, and Rho-kinase in humans.
    Noma K; Goto C; Nishioka K; Hara K; Kimura M; Umemura T; Jitsuiki D; Nakagawa K; Oshima T; Chayama K; Yoshizumi M; Higashi Y
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2630-5. PubMed ID: 16210569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients.
    Büssemaker E; Herbrig K; Pistrosch F; Palm C; Passauer J
    Atherosclerosis; 2009 Dec; 207(2):567-72. PubMed ID: 19717154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome.
    Schinzari F; Tesauro M; Rovella V; Di Daniele N; Gentileschi P; Mores N; Campia U; Cardillo C
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E806-11. PubMed ID: 22829585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans.
    Noma K; Higashi Y; Jitsuiki D; Hara K; Kimura M; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
    Hypertension; 2003 May; 41(5):1102-5. PubMed ID: 12682081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure.
    Hirooka Y; Imaizumi T; Harada S; Masaki H; Momohara M; Tagawa T; Takeshita A
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S221-5. PubMed ID: 1282977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.
    Nohria A; Grunert ME; Rikitake Y; Noma K; Prsic A; Ganz P; Liao JK; Creager MA
    Circ Res; 2006 Dec; 99(12):1426-32. PubMed ID: 17095725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
    Noma K; Goto C; Nishioka K; Jitsuiki D; Umemura T; Ueda K; Kimura M; Nakagawa K; Oshima T; Chayama K; Yoshizumi M; Liao JK; Higashi Y
    J Am Coll Cardiol; 2007 Feb; 49(6):698-705. PubMed ID: 17291936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase inhibitors Y-27632 and fasudil prevent agonist-induced vasospasm in human radial artery.
    Disli OM; Ozdemir E; Berkan O; Bagcivan I; Durmus N; Parlak A
    Can J Physiol Pharmacol; 2009 Aug; 87(8):595-601. PubMed ID: 19767883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.
    Bank AJ; Shammas RA; Mullen K; Chuang PP
    J Card Fail; 1998 Sep; 4(3):193-201. PubMed ID: 9754590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.
    Fujita H; Fukumoto Y; Saji K; Sugimura K; Demachi J; Nawata J; Shimokawa H
    Heart Vessels; 2010 Mar; 25(2):144-9. PubMed ID: 20339976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the ATP-dependent potassium channel attenuates norepinephrine-induced vasoconstriction in the human forearm.
    Pickkers P; Jansen Van Rosendaal AJ; Van Der Hoeven JG; Smits P
    Shock; 2004 Oct; 22(4):320-5. PubMed ID: 15377886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasudil inhibits the myogenic response in the fetal pulmonary circulation.
    Tourneux P; Chester M; Grover T; Abman SH
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1505-13. PubMed ID: 18676688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.
    Fukumoto Y; Matoba T; Ito A; Tanaka H; Kishi T; Hayashidani S; Abe K; Takeshita A; Shimokawa H
    Heart; 2005 Mar; 91(3):391-2. PubMed ID: 15710736
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
    Badejo AM; Dhaliwal JS; Casey DB; Gallen TB; Greco AJ; Kadowitz PJ
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L828-36. PubMed ID: 18689606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased skeletal muscle vasodilation in patients with congestive heart failure.
    Imaizumi T; Hirooka Y; Takeshita A
    Jpn Circ J; 1992 May; 56(5):500-3. PubMed ID: 1534858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
    Okamura N; Saito M; Mori A; Sakamoto K; Kametaka S; Nakahara T; Ishii K
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):207-12. PubMed ID: 17593003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
    Demiryürek S; Kara AF; Celik A; Babül A; Tarakçioglu M; Demiryürek AT
    Eur J Pharmacol; 2005 Dec; 527(1-3):129-40. PubMed ID: 16307738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.